Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This clinical trial studies filgrastim (G-CSF) with or without plerixafor in treating
patients with multiple myeloma (MM) previously treated with lenalidomide. Giving
colony-stimulating factors, such as G-CSF, and plerixafor helps stem cells move from the
patient's bone marrow to the blood so they can be collected and stored